Volume 33, No 1, Jan 2023
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 33 Issue 1, January 2023: 1-2
RASON, a new player in cancer’s Premier League
Sara Mainardi , Rene Bernards*Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Mutations in the KRAS oncogene drive proliferation of 30% of all human cancers, for which effective targeted therapies are still urgently needed. In a recent study published in Cell Research, Cheng et al. report the identification of a new player in the KRAS game which could pave the road for yet unexplored therapeutic strategies.